STAAR SURGICAL CO (STAA)
US8523123052 - Common Stock
STAA gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 188 industry peers in the Health Care Equipment & Supplies industry. STAA scores excellent points on both the profitability and health parts. This is a solid base for a good stock. STAA is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make STAA suitable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year STAA was profitable.
STAA had a positive operating cash flow in the past year.
In the past 5 years STAA has always been profitable.
In the past 5 years STAA always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of STAA (4.05%) is better than 79.14% of its industry peers.
STAA's Return On Equity of 5.09% is fine compared to the rest of the industry. STAA outperforms 76.47% of its industry peers.
The Return On Invested Capital of STAA (4.05%) is better than 74.87% of its industry peers.
The Average Return On Invested Capital over the past 3 years for STAA is in line with the industry average of 8.23%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.05% | ||
| ROE | 5.09% | ||
| ROIC | 4.05% |
ROA(3y)6.93%
ROA(5y)5.97%
ROE(3y)8.89%
ROE(5y)7.69%
ROIC(3y)7.4%
ROIC(5y)5.91%
1.3 Margins
STAA's Profit Margin of 6.38% is fine compared to the rest of the industry. STAA outperforms 78.07% of its industry peers.
STAA's Profit Margin has improved in the last couple of years.
The Operating Margin of STAA (7.53%) is better than 74.87% of its industry peers.
STAA's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 78.73%, STAA belongs to the best of the industry, outperforming 91.98% of the companies in the same industry.
In the last couple of years the Gross Margin of STAA has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.53% | ||
| PM (TTM) | 6.38% | ||
| GM | 78.73% |
OM growth 3Y27.96%
OM growth 5Y10.36%
PM growth 3Y22.42%
PM growth 5Y10.43%
GM growth 3Y2.67%
GM growth 5Y1.21%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so STAA is destroying value.
STAA has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, STAA has more shares outstanding
STAA has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 8.55 indicates that STAA is not in any danger for bankruptcy at the moment.
STAA has a better Altman-Z score (8.55) than 86.10% of its industry peers.
STAA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.55 |
ROIC/WACC0.45
WACC9.05%
2.3 Liquidity
STAA has a Current Ratio of 5.99. This indicates that STAA is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 5.99, STAA is in the better half of the industry, outperforming 79.68% of the companies in the same industry.
A Quick Ratio of 5.38 indicates that STAA has no problem at all paying its short term obligations.
The Quick ratio of STAA (5.38) is better than 80.21% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.99 | ||
| Quick Ratio | 5.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 62.71% over the past year.
The Earnings Per Share has been growing by 43.10% on average over the past years. This is a very strong growth
Looking at the last year, STAA shows a quite strong growth in Revenue. The Revenue has grown by 10.00% in the last year.
STAA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.06% yearly.
EPS 1Y (TTM)62.71%
EPS 3Y71%
EPS 5Y43.1%
EPS Q2Q%26.67%
Revenue 1Y (TTM)10%
Revenue growth 3Y25.4%
Revenue growth 5Y21.06%
Sales Q2Q%10.31%
3.2 Future
STAA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.82% yearly.
STAA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.86% yearly.
EPS Next Y22.97%
EPS Next 2Y16.19%
EPS Next 3Y20.98%
EPS Next 5Y26.82%
Revenue Next Year6.43%
Revenue Next 2Y9.35%
Revenue Next 3Y11.32%
Revenue Next 5Y14.86%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 27.74, the valuation of STAA can be described as expensive.
STAA's Price/Earnings ratio is rather cheap when compared to the industry. STAA is cheaper than 80.21% of the companies in the same industry.
STAA's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.96.
Based on the Price/Forward Earnings ratio of 32.88, the valuation of STAA can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of STAA indicates a somewhat cheap valuation: STAA is cheaper than 74.33% of the companies listed in the same industry.
STAA's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.74 | ||
| Fwd PE | 32.88 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, STAA is valued a bit cheaper than the industry average as 70.59% of the companies are valued more expensively.
STAA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. STAA is cheaper than 77.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 49.9 | ||
| EV/EBITDA | 31.47 |
4.3 Compensation for Growth
STAA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
STAA has a very decent profitability rating, which may justify a higher PE ratio.
STAA's earnings are expected to grow with 20.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.21
PEG (5Y)0.64
EPS Next 2Y16.19%
EPS Next 3Y20.98%
5. Dividend
5.1 Amount
No dividends for STAA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
STAAR SURGICAL CO
NASDAQ:STAA (11/21/2024, 8:00:01 PM)
After market: 26.63 0 (0%)26.63
+0.31 (+1.18%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap1.31B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.74 | ||
| Fwd PE | 32.88 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.21
PEG (5Y)0.64
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.05% | ||
| ROE | 5.09% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 7.53% | ||
| PM (TTM) | 6.38% | ||
| GM | 78.73% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 5.99 | ||
| Quick Ratio | 5.38 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)62.71%
EPS 3Y71%
EPS 5Y
EPS Q2Q%
EPS Next Y22.97%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)10%
Revenue growth 3Y25.4%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y